by Eclosion Team | Jun 25, 2020 | Uncategorized
Geneva, Switzerland, June 25, 2020–7:30 amCEST –GeNeuro (Euronext Paris: CH0308403085 -GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseasessuch as multiple sclerosis...